tirzepatide and retatrutide vs dosage chart: complete comparison guide for every dose GLP-1 Comparison 2026: Semaglutide vs

Question 4: Will I have to be on this medication forever, and what happens if I stop

Early initiation of basic skill education enables patients to acquire essential diabetes management skills and receive supervised practice to enhance their confidence and competence before transitioning to home care

Across the three pivotal trials, peak mean body-weight reductions rank retatrutide 12 mg at 24.2% (48 weeks, Phase 2), tirzepatide 15 mg at 22.5% (72 weeks, Phase 3), and semaglutide 2.4 mg at 14.9% (68 weeks, Phase 3) [1][2][5]

Both treatments are safe, effective and clinically proven- but they work slightly differently